Ultra-Low-Temp Provider Setting Up Organizations to Handle COVID-19 Vaccines

Stirling Ultracold is equipping pharmaceutical companies, a delivery service, a testing facility and a U.S. state health department with NatRef fridges to store COVID-19 vaccines.

As U.S. biotech firm Moderna announced this week that its COVID-19 vaccine had more than 94.5% effectiveness in clinical trials, another U.S. firm, Stirling Ultracold, is touting a novel cooling technology that can keep that vaccine at its required low temperature (-20°C/-4°F).

Stirling Ultracold’s system can also accommodate the -70°C (-94°F) temperature required by the COVID-19 vaccines developed by Pfizer, which announced a 95% efficacy rate in its trials this week. (Another refrigeration provider, Mirai Intex, is also marketing ultra-low-temperature (ULT) air-cycle systems that can handle the Pfizer vaccine.)

Stirling Ultracold is already equipping pharmaceutical companies, a delivery service, a testing facility and a U.S. state health department with ULT fridges to store COVID-19 vaccines.

“We understand that we’re in a unique position to be an integral part of a global public health effort, and we’re working around the clock to ensure vaccines will arrive to everyone safely and with as little product loss as possible,” said Dusty Tenney, CEO, Akron, Ohio (U.S.)-based Stirling Ultracold, in a statement.

 

Read the entire article at HydroCarbons: http://hydrocarbons21.com/articles/9831/ultra_low_temp_provider_setting_up_organizations_to_handle_covid_19_vaccines